Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 3, 2012
Issued Date -
N/A
app pub date -
Jun 24, 2009
filing date -
Sep 7, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Methods for stabilizing β-galactosidase, stabilizing β-glucocerebrosidase, treating a glycolipid metabolic disorder caused by mutation of β-galactosidase gene, treating a glycolipid metabolic disorder caused by mutation of β-glucocerebrosidase gene, regenerating the activity of β-galactosidase, regenerating the activity of β-glucosidase, treating GM1 gangliosidosis, Morquio-B or Krabbe's disease, and treating Gaucher's disease, include administering a carba-sugar amine derivative represented by the following formula (1) or (2):
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully